Related references
Note: Only part of the references are listed.Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease
Carlos Estevez-Fraga et al.
MOVEMENT DISORDERS (2021)
Sensitivity of quantitative relaxometry and susceptibility mapping to microscopic iron distribution
Timothy J. Colgan et al.
MAGNETIC RESONANCE IN MEDICINE (2020)
Robust Markers and Sample Sizes for Multicenter Trials of Huntington Disease
Peter A. Wijeratne et al.
ANNALS OF NEUROLOGY (2020)
MR biomarkers of degenerative brain disorders derived from diffusion imaging
Christina Andica et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)
Striatal iron content is linked to reduced fronto-striatal brain function under working memory load
Karen M. Rodrigue et al.
NEUROIMAGE (2020)
Complementarity of gluCEST and 1H-MRS for the study of mouse models of Huntington's disease
Jeremy Pepin et al.
NMR IN BIOMEDICINE (2020)
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington?s disease Young Adult Study (HD-YAS): a cross-sectional analysis
Rachael I. Scahill et al.
LANCET NEUROLOGY (2020)
Quantifying iron content in magnetic resonance imaging
Kiarash Ghassaban et al.
NEUROIMAGE (2019)
Fluid and imaging biomarkers for Huntington's disease
Paul Zeun et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials
Hans-Peter Mueller et al.
PARKINSONISM & RELATED DISORDERS (2019)
Detecting Microglial Density With Quantitative Multi-Compartment Diffusion MRI
Sue Y. Yi et al.
FRONTIERS IN NEUROSCIENCE (2019)
Diffusion Tensor Imaging in Preclinical and Human Studies of Huntington's Disease: What Have We Learned so Far?
Rodolfo Gabriel Gatto et al.
CURRENT MEDICAL IMAGING (2019)
Altered brain iron content and deposition rate in Huntington's disease as indicated by quantitative susceptibility MRI
Lin Chen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2019)
Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease
Clara Garcia-Gorro et al.
NEUROIMAGE-CLINICAL (2019)
TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31
Danielle A. Simmons et al.
HUMAN MOLECULAR GENETICS (2018)
A whole brain longitudinal study in the YAC128 mouse model of Huntington's disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes
Lorena I. Petrella et al.
HUMAN MOLECULAR GENETICS (2018)
Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease
Xiao Zhou et al.
HUMAN MOLECULAR GENETICS (2018)
Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease
H. D. Rosas et al.
NEUROIMAGE-CLINICAL (2018)
In vivo characterization of white matter pathology in premanifest huntington's disease
Jiaying Zhang et al.
ANNALS OF NEUROLOGY (2018)
Connectomic imaging reveals Huntington-related pathological and pharmaceutical effects in a mouse model
Wei-Tang Chang et al.
NMR IN BIOMEDICINE (2018)
Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas
Patrik Fazio et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward
Edina Silajdzic et al.
JOURNAL OF HUNTINGTONS DISEASE (2018)
Disruption of neurite morphology parallels MS progression
Barbara Spano et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Brain Diffusivity and Structural Changes in the R6/2 Mouse Model of Huntington Disease
Ivan Vorisek et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Disease Stage and Plasma Levels of Cytokines in Huntington's Disease: A 2-Year Follow-Up Study
Joseph A. Bouwens et al.
MOVEMENT DISORDERS (2017)
Urinary p75ECD A prognostic, disease progression, and pharmacodynamic biomarker in ALS
Stephanie R. Shepheard et al.
NEUROLOGY (2017)
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington's Disease
Ivan Rattray et al.
PLOS ONE (2017)
NODDI-DTI: Estimating Neurite Orientation and Dispersion Parameters from a Diffusion Tensor in Healthy White Matter
Luke J. Edwards et al.
FRONTIERS IN NEUROSCIENCE (2017)
Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort
Rui Jia et al.
SCIENTIFIC REPORTS (2017)
Resting-state functional MRI reveals altered brain connectivity and its correlation with motor dysfunction in a mouse model of Huntington's disease
Qiang Li et al.
SCIENTIFIC REPORTS (2017)
Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington's Disease
Danielle A. Simmons
JOURNAL OF HUNTINGTONS DISEASE (2017)
Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington's Disease
Danielle A. Simmons et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2017)
A Brain-Derived Neurotrophic Factor-Based p75NTR Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination
David G. Gonsalvez et al.
ENEURO (2017)
Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease
J. M. G. van Bergen et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study
Juan F. D. Dominguez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Potential biomarkers to follow the progression and treatment response of Huntington's disease
Marie-Helene Disatnik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Accumulation of iron in the putamen predicts its shrinkage in healthy older adults: A multi-occasion longitudinal study
Ana M. Daugherty et al.
NEUROIMAGE (2016)
Diffusion imaging studies of Huntington's disease: A meta-analysis
Wanglin Liu et al.
PARKINSONISM & RELATED DISORDERS (2016)
Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease
Qi Peng et al.
PLOS ONE (2016)
Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?
Lucie Hopes et al.
PLOS ONE (2016)
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
Marta Garcia-Miralles et al.
SCIENTIFIC REPORTS (2016)
Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy
Stephen J. Sawiak et al.
JOURNAL OF HUNTINGTONS DISEASE (2016)
Plasma inflammatory biomarkers for Huntington's disease patients and mouse model
Kuo-Hsuan Chang et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation
Andres Miguez et al.
HUMAN MOLECULAR GENETICS (2015)
A Longitudinal Study of Magnetic Resonance Spectroscopy Huntington's Disease Biomarkers
Aaron Sturrock et al.
MOVEMENT DISORDERS (2015)
Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker
S-S Jiao et al.
TRANSLATIONAL PSYCHIATRY (2015)
The Role of Iron in Gray Matter Degeneration in Huntington's Disease: A Magnetic Resonance Imaging Study
Cristina Sanchez-Castaneda et al.
HUMAN BRAIN MAPPING (2015)
Correlation between Relaxometry and Diffusion Tensor Imaging in the Globus Pallidus of Huntington's Disease Patients
Michael Syka et al.
PLOS ONE (2015)
Quantitative 7T Phase Imaging in Premanifest Huntington Disease
A. C. Apple et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Acute-phase proteins in relation to neuropsychiatric symptoms and use of psychotropic medication in Huntington's disease
J. A. Bouwens et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Neurotrophin receptor p75NTR mediates Huntington's disease-associated synaptic and memory dysfunction
Veronica Brito et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Iron dysregulation in Huntington's disease
Michelle Muller et al.
JOURNAL OF NEUROCHEMISTRY (2014)
White matter connectivity reflects clinical and cognitive status in Huntington's disease
Govinda R. Poudel et al.
NEUROBIOLOGY OF DISEASE (2014)
Disentangling in vivo the effects of iron content and atrophy on the ageing human brain
S. Lorio et al.
NEUROIMAGE (2014)
Impaired TrkB Receptor Signaling Underlies Corticostriatal Dysfunction in Huntington's Disease
Joshua L. Plotkin et al.
NEURON (2014)
The Extracellular Domain of Neurotrophin Receptor p75 as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
Stephanie R. Shepheard et al.
PLOS ONE (2014)
A Small Molecule p75NTR Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression
Danielle A. Simmons et al.
PLOS ONE (2014)
Understanding logistic regression analysis
Sandro Sperandei
BIOCHEMIA MEDICA (2014)
Seeking huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging
Cristina Sanchez-Castaneda et al.
HUMAN BRAIN MAPPING (2013)
Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury
Chhavy Tep et al.
JOURNAL OF NEUROSCIENCE (2013)
A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease
Danielle A. Simmons et al.
JOURNAL OF NEUROSCIENCE (2013)
Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease
Frank M. Longo et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model
Juliet K. Knowles et al.
NEUROBIOLOGY OF AGING (2013)
Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials
Nellie Georgiou-Karistianis et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/1 Mouse Model of Huntington's Disease
Ivan Rattray et al.
PLOS ONE (2013)
Iron Accumulates in Huntington's Disease Neurons: Protection by Deferoxamine
Jianfang Chen et al.
PLOS ONE (2013)
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
Kirupa Sathasivam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Imbalance of p75NTR/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies
V. Brito et al.
CELL DEATH & DISEASE (2013)
Alterations in Brain Transition Metals in Huntington Disease An Evolving and Intricate Story
H. Diana Rosas et al.
ARCHIVES OF NEUROLOGY (2012)
Multimodal MRI Analysis of the Corpus Callosum Reveals White Matter Differences in Presymptomatic and Early Huntington's Disease
M. Di Paola et al.
CEREBRAL CORTEX (2012)
R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures
Efrain Cepeda-Prado et al.
JOURNAL OF NEUROSCIENCE (2012)
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2012)
Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging
Manisha Aggarwal et al.
NEUROIMAGE (2012)
Elevated brain iron is independent from atrophy in Huntington's Disease
Eve M. Dumas et al.
NEUROIMAGE (2012)
NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain
Hui Zhang et al.
NEUROIMAGE (2012)
Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease
Fernando Sanchez-Lopez et al.
NEUROLOGICAL RESEARCH (2012)
Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review
Graziella Orru et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington's Disease: zQ175
Liliana B. Menalled et al.
PLOS ONE (2012)
Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease
Taneli Heikkinen et al.
PLOS ONE (2012)
PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease
Robert A. Cherny et al.
JOURNAL OF HUNTINGTONS DISEASE (2012)
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2011)
Natural history of disease in the YAC128 mouse reveals a discrete signature of pathology in Huntington disease
Jeffrey B. Carroll et al.
NEUROBIOLOGY OF DISEASE (2011)
Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
Yong Cheng et al.
NEUROIMAGE (2011)
Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques
Angela Rizk-Jackson et al.
NEUROIMAGE (2011)
Statistical adjustments for brain size in volumetric neuroimaging studies: Some practical implications in methods
Liam M. O'Brien et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
p75 Neurotrophin Receptor-mediated Apoptosis in Sympathetic Neurons Involves a Biphasic Activation of JNK and Up-regulation of Tumor Necrosis Factor-α-converting Enzyme/ADAM17
Rajappa S. Kenchappa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neuroinflammation in Huntington's disease
Thomas Moeller
JOURNAL OF NEURAL TRANSMISSION (2010)
Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images
Jiangyang Zhang et al.
NEUROIMAGE (2010)
The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo
Juliet K. Knowles et al.
JOURNAL OF NEUROSCIENCE (2009)
Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease
S. J. Sawiak et al.
NEUROBIOLOGY OF DISEASE (2009)
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Liliana Menalled et al.
NEUROBIOLOGY OF DISEASE (2009)
Bayesian analysis of neuroimaging data in FSL
Mark W. Woolrich et al.
NEUROIMAGE (2009)
In vivo evidence for the selective subcortical degeneration in Huntington's disease
Gwenaelle Douaud et al.
NEUROIMAGE (2009)
Automatic detection of preclinical neurodegeneration Presymptomatic Huntington disease
S. Kloeppel et al.
NEUROLOGY (2009)
Distinct neuroinflammatory profile in post-mortem human Huntington's disease
Aurelio Silvestroni et al.
NEUROREPORT (2009)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Bjorkqvist et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Detection of Huntington's disease decades before diagnosis: the Predict-HD study
J. S. Paulsen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment
Tao Yang et al.
PLOS ONE (2008)
Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease
Chiara Zuccato et al.
BRAIN PATHOLOGY (2008)
Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease
Danielle A. Simmons et al.
GLIA (2007)
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
Annette Dalrymple et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures
H. Diana Rosas et al.
MOVEMENT DISORDERS (2006)
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
Paul A. Yushkevich et al.
NEUROIMAGE (2006)
Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death
Stephen M. Massa et al.
JOURNAL OF NEUROSCIENCE (2006)
Adaptive linear step-up procedures that control the false discovery rate
Yoav Benjamini et al.
BIOMETRIKA (2006)
Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model
T Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Advances in functional and structural MR image analysis and implementation as FSL
SM Smith et al.
NEUROIMAGE (2004)
Evidence for more widespread cerebral pathology in early HD - An MRI-based morphometric analysis
HD Rosas et al.
NEUROLOGY (2003)
The neurotrophin receptor p75NTR as a positive modulator of myelination
JM Cosgaya et al.
SCIENCE (2002)
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
M Chen et al.
NATURE MEDICINE (2000)
Share Paper
